Company

Recludix Pharma, Inc.

Recludix Pharma develops therapeutics for inflammatory diseases.

About

Founded in 2019 and based in San Diego, Recludix Pharma researches therapeutics for inflammatory diseases, focusing on biologically validated targets including SH2 domains. On November 15, 2021, it raised USD 60.00 mn in Series A funding, with participation from Access Industries, New Enterprise Associates, and Westlake Village BioPartners.

1Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in